Klug entscheiden in der Nephrologie

 

 

Literaturnachweise

  1. KDIGO: 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl 2013; 3: 1–150. 
  2. Hasegawa T, Bragg-Gresham JL, Yamazaki S, et al.: Greater first-year survival on hemodialysis in facilities in which patients are provided earlier and more frequent pre-nephrology visits. Clin J Am Soc Nephrol 2009; 4: 595–602. 
  3. Girndt M, Trocchi P, Scheidt-Nave C, Markau S, Stang A: The Prevalence of Renal Failure. Dtsch Arztebl Int 2016; 113(6): 85–91. 
  4. Matsushita K, Coresh J, Sang Y, Chalmers J, Fox C, et al.: Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data. Lancet Diabetes Endocrinol 2015; 3: 514–25. 
  5. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann Intern Med 1999; 130: 461–70. 
  6. Levey AS, Stevens LA, Schmid CH, et al.: A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604–12. 
  7. Levin A, Bakris GL, Molitch M, et al.: Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the study to evaluate early kidney disease. Kidney Int 2007; 71: 31–8. 
  8. Moranne O, Froissart M, Rossert J, et al.: Timing of onset of CKD-related metabolic complications. J Am Soc Nephrol 2009; 20: 164–71. 
  9. Vassalotti JA, Uribarri J, Chen SC, et al.: Trends in mineral metabolism: Kidney Early Evaluation Program (KEEP) and the National Health and Nutrition Examination Survey (NHANES) 1999–2004. Am J Kidney Dis 2008; 51: S56–S68. 
  10. Stevens LA, Djurdjev O, Cardew S, Cameron EC, Levin A: Calcium, phosphate, and parathyroid hormone levels in combination and as a function of dialysis duration predict mortality: evidence for the complexity of the association between mineral metabolism and outcomes. J Am Soc Nephrol 2004; 15: 770–9. 
  11. Shlipak MG, Heidenreich PA, Noguchi H, Chertow GM, Browner WS, McClellan MB: Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann Intern Med 2002; 137: 555–62. 
  12. Newhouse JH, Kho D, Rao QA, Starren J: Frequency of serum creatinine changes in the absence of iodinated contrast material: implications for studies of contrast nephrotoxicity. AJR Am J Roentgenol 2008; 191: 376–82. 
  13. Cely CM, Schein RM, Quartin AA: Risk of contrast induced nephropathy in the critically ill: a prospective, case matched study. Crit Care 2012; 16: R67. 
  14. Baumgarten DA, Ellis JH: Contrast-induc - ed nephropathy: contrast material not required? AJR Am J Roentgenol 2008; 191: 383–6. 
  15. Katzberg RW, Newhouse JH: Intravenous contrast medium-induced nephrotoxicity: is the medical risk really as great as we have come to believe? Radiology 2010; 256: 21–8. 
  16. Davenport MS, Cohan RH, Ellis JH: Contrast media controversies in 2015: imaging patients with renal impairment or risk of contrast reaction. AJR Am J Roentgenol. 2015; 204: 1174–81. 
  17. Thomsen HS, Stacul F: CIN: can we forget it? Acta Radiol 2014; 55: 1027–30. 
  18. Kausz A, Pahari D: The value of vaccination in chronic kidney disease. Semin Dial 2004; 17: 9–11. 
  19. Wiese-Posselt M, Tertilt C, Zepp F: Vaccination recommendations for Germany. Dtsch Arztebl Int 2011; 108(45): 771–80. 
  20. National Kidney Foundation: A guide for adults with chronic kidney disease or kidney failure living on dialysis or with a kidney transplantguide for adults with chronic kidney disease or kidney failure living on dialysis or with a kidney transplant. www kidney org/atoz/content/ vaccinations. 2016. 
  21. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 2009; 9 Suppl 3: S1–155. 
  22. Palmer SC, Wong G, Iff S, et al.: Fluid in - take and all-cause mortality, cardiovascular mortality and kidney function: a population- based longitudinal cohort study. Nephrol Dial Transplant 2014; 29: 1377–84. 
  23. Grams ME, Estrella MM, Coresh J, Brower RG, Liu KD: Fluid balance, diuretic use, and mortality in acute kidney injury. Clin J Am Soc Nephrol 2011; 6: 966–73. 
  24. Payen D, de Pont AC, Sakr Y, Spies C, Reinhart K, Vincent JL: A positive fluid balance is associated with a worse out - come in patients with acute renal failure. Crit Care 2008; 12: R74. 
  25. Bouchard J, Soroko SB, Chertow GM, et al.: Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. Kidney Int 2009; 76: 422–7. 
  26. Cantarovich F, Rangoonwala B, Lorenz H, Verho M, Esnault VL: High-dose furosemide for established ARF: a prospective, randomized, double-blind, placebo-controlled, multicenter trial. Am J Kidney Dis 2004; 44: 402–9. 
  27. Ho KM, Power BM: Benefits and risks of furosemide in acute kidney injury. Anaesthesia 2010; 65: 283–93. 
  28. Kellum JA, Lameire N: Diagnosis, evalu - ation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care 2013; 17: 204. 
  29. Wheatley K, Ives N, Gray R, et al.: Revascularization versus medical therapy for renal- artery stenosis. N Engl J Med 2009; 361: 1953–62. 
  30. 30. Cooper CJ, Murphy TP, Cutlip DE, Jamerson K, Henrich W, et al.: Stenting and medical therapy for atherosclerotic renalartery stenosis. N Engl J Med 2014; 370: 13–22. 
  31. Ritchie J, Alderson HV, Kalra PA: Where now in the management of renal artery stenosis? Implications of the ASTRAL and CORAL trials. Curr Opin Nephrol Hypertens 2014; 23: 525–32. 
  32. Rahman S, Malcoun A: Nonsteroidal antiinflammatory drugs, cyclooxygenase-2, and the kidneys. Prim Care 2014; 41: 803–21. 
  33. Gurwitz JH, Avorn J, Bohn RL, Glynn RJ, Monane M, Mogun H: Initiation of antihypertensive treatment during nonstero - idal anti-inflammatory drug therapy. JAMA 1994; 272: 781–6.

Um die unsere Webseite optimal gestalten zu können, werden Cookies verwendet. Durch die weitere Nutzung der Webseite der DGIM stimmen Sie der Verwendung von Cookies zu. Weitere Informationen zu Cookies und zum Datenschutz erfahren Sie hier

Checkbox kommt...